CSIMarket Company Name, Ticker, Competitors, else..
 
Niagen Bioscience Inc   (NASDAQ: NAGE)
 
Price: $3.1300 $0.00 0.000%
Day's High: $3.1500000953674316 Week Perf: -5.15 %
Day's Low: $ 3.08 30 Day Perf: -11.33 %
Volume (M): 282,958 52 Wk High: $ 10.52
Volume (M$): $ 0 52 Wk Avg: $5.43
Open: $3.11 52 Wk Low: $2.87



 Market Capitalization (Millions $) 258
 Shares Outstanding (Millions) 83
 Employees 117
 Revenues (TTM) (Millions $) 129
 Net Income (TTM) (Millions $) 16
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) 0

Business Description


Niagen Bioscience, Inc. is a global bioscience company focused on researching and commercializing nicotinamide adenine dinucleotide (NAD+) precursors, including their proprietary ingredient Niagen®, a form of vitamin B3. The company develops and supplies food-grade and pharmaceutical-grade Niagen® for use in dietary supplements, food products, and prescription compounding. Niagen Bioscience also markets consumer products under the Tru Niagen® brand through direct-to-consumer and international channels.


   Company Address: 10900 Wilshire Blvd Los Angeles 90024 CA
   Company Phone Number: 388-6706   Stock Exchange / Ticker: NASDAQ NAGE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Business Update

Niagen Bioscience Innovates Resilience Navigating Tariffs in the Pursuit of Healthy Aging,

Published Mon, Apr 7 2025 4:26 PM UTC

In a rapidly changing global economic landscape, Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly known as ChromaDex Corp. reaffirms its unwavering commitment to innovative health solutions and resilient operational capacity. Known globally as the authority on NAD+ (nicotinamide adenine dinucleotide) and its applications in healthy aging, Niagen Bioscience has demonstrated i...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 17.39
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.00
Price to Sales (Expected) -
Price to Book 3.13
PEG (TTM) -

Financial Strength Current
Quick Ratio -
Working Capital Ratio 6.5
Leverage Ratio (MRQ) 0.29
Total Debt to Equity -
Interest Coverage (TTM) 11.92
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0.18 $
Revenues (TTM) 1.56 $
Cash Flow (TTM) 0.07 $
Cash -
Book Value 1 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 1,103,282
Net Income per Employee (TTM) 136,675
Receivable Turnover Ratio (TTM) 12.94
Inventory Turnover Ratio (TTM) 2.2
Asset Turnover Ratio (TTM) 1.22

Profitability Ratios Current
Gross Margin (MRQ) 64.84 %
Operating Margin (MRQ) 2.35 %
Net Margin (MRQ) 3.23 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 6.09 %

Management Effectiveness Current
Return On Assets (TTM) 15.08 %
Return On Investment (TTM) 18.54 %
Return On Equity (TTM) 20.5 %
Dividend Yield -
Pay out Ratio (TTM) -



Niagen Bioscience Inc's Segments
Corporate and other    0.24 % of total Revenue
Consumer Products segment    71.21 % of total Revenue
Ingredients segment    27.21 % of total Revenue
Analytical Reference Standards and Services segment    1.34 % of total Revenue
Subtotal Niagen Related    97.13 % of total Revenue
Tru Niagen Consumer Product    71.21 % of total Revenue
Food-grade Niagen    23.22 % of total Revenue
Pharmaceutical-grade Niagen    2.7 % of total Revenue
Subtotal Other Goods and Services    2.87 % of total Revenue
Other Ingredients    1.29 % of total Revenue
Reference Standards    1.31 % of total Revenue
Consulting and Other    0.27 % of total Revenue
Consumer Products Subtotal Niagen Related    71.21 % of total Revenue
Consumer Products Tru Niagen Consumer Product    71.21 % of total Revenue
Ingredients Subtotal Niagen Related    25.92 % of total Revenue
Ingredients Food-grade Niagen    23.22 % of total Revenue
Ingredients Pharmaceutical-grade Niagen    2.7 % of total Revenue
Ingredients Subtotal Other Goods and Services    1.29 % of total Revenue
Ingredients Other Ingredients    1.29 % of total Revenue
Analytical Reference Standards and Services Subtotal Other Goods and Services    1.34 % of total Revenue
Analytical Reference Standards and Services Reference Standards    1.31 % of total Revenue
Analytical Reference Standards and Services Consulting and Other    0.04 % of total Revenue
Corporate and other Subtotal Other Goods and Services    0.24 % of total Revenue
Corporate and other Consulting and Other    0.24 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.